Athersys Inc (ATHX) - Financial and Strategic SWOT Analysis Review

May 2021 | 53 pages | ID: A46B3698D1CEN
GlobalData

Abstracts

Athersys Inc (ATHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Athersys Inc (Athersys) is a biotechnology company that discovers and develops novel and proprietary therapies in the field of regenerative medicine. It is investigating its lead platform, MultiStem, a patented stem cell product for treating chronic conditions such as cardiovascular diseases, inflammatory and immune disorders, neurological conditions and pulmonary disorders. Its MultiStem program includes product candidates at various levels of clinical trials for treating acute myocardial infarction, bone marrow/hematopoietic stem cell transplantation, ischemic stroke and autoimmune disease. Athersys is headquartered in Cleveland, Ohio, the US.

Athersys Inc Key Recent Developments

May 06,2021: Athersys Reports First Quarter 2021 Results
Apr 01,2021: Athersys to Present at the Needham Virtual Healthcare Conference on April 14
Mar 25,2021: Athersys Announces Financial Results for Fourth Quarter and Full Year 2020
Mar 02,2021: Athersys to Host Year-End 2020 Financial Results Call
Nov 16,2020: Athersys announces three appointments to Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Athersys Inc - Key Facts
Athersys Inc - Key Employees
Athersys Inc - Key Employee Biographies
Athersys Inc - Major Products and Services
Athersys Inc - History
Athersys Inc - Company Statement
Athersys Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate

SECTION 2 – COMPANY ANALYSIS

Company Overview
Athersys Inc - Business Description
Business Segment: Contract Revenue
Performance
Business Segment: Grant Revenue
Performance
R&D Overview
Athersys Inc - Corporate Strategy
Athersys Inc - SWOT Analysis
SWOT Analysis - Overview
Athersys Inc - Strengths
Athersys Inc - Weaknesses
Athersys Inc - Opportunities
Athersys Inc - Threats
Athersys Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Athersys Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Athersys Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 06, 2021: Athersys Reports First Quarter 2021 Results
Apr 01, 2021: Athersys to Present at the Needham Virtual Healthcare Conference on April
Mar 25, 2021: Athersys Announces Financial Results for Fourth Quarter and Full Year 2020
Mar 02, 2021: Athersys to Host Year-End 2020 Financial Results Call
Nov 16, 2020: Athersys announces three appointments to Board of Directors
Nov 09, 2020: Athersys reports third quarter 2020 results and provides corporate update
Aug 10, 2020: Athersys reports second quarter 2020 results
May 07, 2020: Athersys reports first quarter 2020 results
Apr 21, 2020: Athersys to Host First Quarter Financial Results Call
Apr 01, 2020: Athersys receives loan under Paycheck Protection Program

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Athersys Inc, Key Facts
Athersys Inc, Key Employees
Athersys Inc, Key Employee Biographies
Athersys Inc, Major Products and Services
Athersys Inc, History
Athersys Inc, Subsidiaries
Athersys Inc, Affiliate
Athersys Inc, Key Competitors
Athersys Inc, Ratios based on current share price
Athersys Inc, Annual Ratios
Athersys Inc, Annual Ratios (Cont...1)
Athersys Inc, Interim Ratios
Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Athersys Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Athersys Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Athersys Inc, Performance Chart (2016 - 2020)
Athersys Inc, Ratio Charts
Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Athersys Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021